ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Nayi Zongo, Bagué Abdoul Halim, Ouangré Edgar, Bagré Sidpawalmde Carine, Zida Maurice, Boukoungou Gilbert, Sanou Adama, Lompo Olga Mélanie, Traoré Si Simon, Ahmadou Dem
Aim : Evaluate the impact of MAGIC trial on gastric adenocarcinoma’s management in Africa. Method and methodology : It was about a review of literature on therapeutic aspects of gastric adenocarcinoma in the African area. We have taken a census of 21 articles…
Hiroshi Yamazaki, Masaki Fujieda, Makiko Shimizu, Akiko Shiotani, Mie Shimabukuro, Kanae Mure, Tatsuya Takeshita, Hideki Ishikawa
The relationships among meat consumption, smoking habits, and phenotypic cytochrome P450 2A6 variation with respect to colorectal cancer risk remain unclear. In this study, the relationships among colorectal tumour risk, meat consumption by questionnaire, and…
Arthur J. Weiss, Irwin L. Stoloff, Antonio C. Simoes
It has been demonstrated that it is safe to give Gm-Csf, together with Doxorubicin, by continuous intravenous infusion, thereby substantially increasing the amount of Doxorubicin administered to the average patient, and assuring that each patient receives an…
Eric Romney, Whitney Wilson, Justin Chen, Trung Nguyen, Omar Jawhar, Aniket Mody, Shaleen Korch, Vinay J Nagaraj
Introduction: Cervical cancer is primarily caused by the human papilloma virus (HPV), which transforms normal cervical cells into cancerous cells that are highly resistant to radiation and chemotherapy. Induction of apoptosis in transformed cells is a key str…
Kirsten H. Walen
Official (NIH) cancer investigation is on identification of inherited cancer genes in you and me for early interventions, and for use of such knowledge in therapy. In this review the emphasis is on the unknown cancer initiation, and on the question of a mecha…
Lamiae Amaadour, Loubna Atreche, Meryem Azegrar, Zineb Benbrahim, Fatima Zahra EL Mrabet, Samia Arifi, Nawfel Mellas
Renal cell carcinoma (RCC) is known as a highly aggressive malignancy with frequent metastasis that the major sites being lungs, lymphatic ganglions, bones, liver and brain. Cutaneous metastasis is uncommon with only a few reported cases in the literature. We…
Mohsen S. Barsoum, Azza Mohamed Nasr, Ikram Hamed Mahmoud, Salem E. Salem, Rasha A. Elawady, Shaimaa Abdelallem, Ahmed Awad
Purpose: To study the effect of escalating radiation dose; in intermediate and high risk prostate cancer patients; via online image-guidance on acute toxicities. Patients and Methods: thirty-eight prostate cancer patients were treated by using simultaneous in…
Ahmed Abo Gabal, Mohamed Lotayef, Hoda Abd Elbaky, Maha Hassan, Heba Elzawahry, Ekram Hamed
Objective: To determine the possible therapeutic gain of using three-dimensional conformal radiotherapy (3D-CRT) as a treatment option for portal vein tumor thrombus (PVTT) in patients with hepatocellular carcinoma (HCC) and to evaluate the tolerance and toxi…
Maria E. Rich, Ping Zhao, Abhinav B. Nagulapally, Jeffrey Bond, Giselle L. Saulnier Sholler
Neuroblastoma (NB) is the most common childhood cancer arising from the nervous system. Many high-risk neuroblastoma (HRNB) patients develop relapse after initial response to induction treatment and overall long term survival remains poor (less than 60%), emp…
Yi-Ren Hu, Ying Yu, Jian-Xin Li, Wei-Chun Lu, Qi-Jin Shu, Ying-Cong Yu
Background and Aim: Chronic atrophic gastritis is a known precancerous lesion for gastric cancer, with an overall 5-year survival less than 20%. However, there is few new data describing the progression rate from atrophic gastritis (AG) to gastric cancer in C…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).